Muscle-specific vascular endothelial growth factor deletion induces muscle capillary rarefaction creating muscle insulin resistance.

Bonner JS, Lantier L, Hasenour CM, James FD, Bracy DP, Wasserman DH
Diabetes. 2013 62 (2): 572-80

PMID: 23002035 · PMCID: PMC3554359 · DOI:10.2337/db12-0354

Muscle insulin resistance is associated with a reduction in vascular endothelial growth factor (VEGF) action and muscle capillary density. We tested the hypothesis that muscle capillary rarefaction critically contributes to the etiology of muscle insulin resistance in chow-fed mice with skeletal and cardiac muscle VEGF deletion (mVEGF(-/-)) and wild-type littermates (mVEGF(+/+)) on a C57BL/6 background. The mVEGF(-/-) mice had an ~60% and ~50% decrease in capillaries in skeletal and cardiac muscle, respectively. The mVEGF(-/-) mice had augmented fasting glucose turnover. Insulin-stimulated whole-body glucose disappearance was blunted in mVEGF(-/-) mice. The reduced peripheral glucose utilization during insulin stimulation was due to diminished in vivo cardiac and skeletal muscle insulin action and signaling. The decreased insulin-stimulated muscle glucose uptake was independent of defects in insulin action at the myocyte, suggesting that the impairment in insulin-stimulated muscle glucose uptake was due to poor muscle perfusion. The deletion of VEGF in cardiac muscle did not affect cardiac output. These studies emphasize the importance for novel therapeutic approaches that target the vasculature in the treatment of insulin-resistant muscle.

MeSH Terms (14)

Animals Blood Glucose Capillaries Gene Deletion Hypoglycemic Agents Insulin Insulin Resistance Mice Mice, Inbred C57BL Muscle, Skeletal Muscle Cells Myocardium Signal Transduction Vascular Endothelial Growth Factor A

Connections (6)

This publication is referenced by other Labnodes entities: